Package Label.Principal Display Panel
Mycratine Label Description
The following Structured Product Label (SPL) was submitted to the FDA by Nico Worldwide, Inc. for the product Mycratine (NDC 42638-7666). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, otc - active ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, inactive ingredient, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Mycratine Label Description
Ingredients
In a base of: Caffeine, L-Tyrosine, L-Tryptophan, L-Phenylalanine
Mycratine Migraine Relief
Advanced Relief Formula
Liquid Shot
Keep out of reach of children.
Indications:
For the relief/treatment of migraines and headaches
Intended for adult use only
Warning:
Do not use if pregnant or breast-feeding or have pheylketonuria.
Consult your doctor or health care professional before use if you are taking prescription medication for depression such as MAO inhibitors or have asthma, high blood pressure, stomach ulcers, diabetes, or hyperthyroidism.
This product contains nicotine, a chemical known to the state of California to cause birth defects or other reproductive harm.
Caution:
Directions:
Inactive Ingredients:
purified water, gum acacia, lemon oil, brominated vegetable oil, ester gum, citric acid, sodium benzoate, sucralose.
* Please review the disclaimer below.